Elevance (ELV) notes that it remains confident in returning to "at least" 12% adjusted EPS growth in 2027, citing progress across the portfolio

#EQUITIES#EU SESSION#US SESSION#MANAGED HEALTH CARE#HEALTH CARE PROVIDERS & SERVICES#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#S&P 500 INDEX#ELEVANCE HEALTH INC#ELV#US EQUITIES
Published: Updated: